Tag: Epidiolex

GW Pharma Phase 3 Data Due Soon

The Financial Times shared a great history of the ups and downs  of GW Pharma (NASDAQ: GWPH), which will soon report the results of the first of four Phase...
- February 1st, 2016 at 9:42 am

This Recent Federal Law Could Help GW Pharma's Epidiolex

GW Pharmaceuticals (NASDAQ: GWPH) reported its fiscal year-end results today and held a conference call after the market closed.  One of the more interesting parts of the prepared remarks involved...
- December 7th, 2015 at 6:20 pm